SC Filed 2018-02-14 Event — SEC 0001144204-18-008574 →

Sofinnova Venture Partners VIII, L.P. → SYNLOGIC, INC. SYBX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

13 13D/G filings on this issuer

12 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.10

32,382 shares short · +952.7% vs prior

Other 13D/G Filings on SYNLOGIC, INC.

Filed	Form	Filer	Stake	Shares
2026-07-29	SCHEDULE 13D/A	New Enterprise Associates 14, L.P.	—	2,922,772	view →
2026-07-29	SCHEDULE 13D/A	Funicular Funds, LP	—	3,312,219	view →
2024-05-16	SC	New Enterprise Associates 14, L.P.	—	—	view →
2023-10-13	SC	New Enterprise Associates 14, L.P.	—	—	view →
2023-10-04	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-09-29	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-04-22	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-03-29	SC	ORBIMED ADVISORS LLC	—	—	view →
2019-08-12	SC	ORBIMED ADVISORS LLC	—	—	view →
2018-04-12	SC	ORBIMED ADVISORS LLC	—	—	view →
2018-02-01	SC	New Enterprise Associates 14, L.P.	—	—	view →
2018-01-26	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by Sofinnova Venture Partners VIII, L.P.

Filed	Form	Issuer	Stake	Shares
2025-02-25	SCHEDULE	NuCana plc NCNA	10.00%	51,030	view →
2022-02-28	SC	ObsEva SA	—	—	view →
2022-02-28	SC	NuCana plc NCNA	—	—	view →
2021-03-04	SC	ObsEva SA	—	—	view →
2019-02-12	SC	Natera, Inc. NTRA	—	—	view →
2018-02-14	SC	Aclaris Therapeutics, Inc. ACRS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →